Infectious Diseases

Mayo Clinic research shows bebtelovimab to be a reliable option for treating COVID-19 in era of BA.2, other subvariants

Adam Harringa

August 15, 2022

ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]

Understanding Drug-resistant Superbugs

Deb Balzer

July 7, 2016

Mayo Researcher Contributes to Immune System Collaboration

Mayo Clinic Staff

July 1, 2016

CDC Says Flu Nasal Spray Doesn’t Work

Vivien Williams

June 23, 2016

Mayo Clinic Q and A: Direct Contact With Cold Sore Could Spread Virus

Liza Torborg

June 11, 2016

Mayo Clinic Q and A: Should I Be Tested for Hepatitis C?

Liza Torborg

June 4, 2016

Yellow Fever Outbreak Concerns

Deb Balzer

June 3, 2016

Mayo Clinic Minute: Rise in Tick-related Meat Allergy

Jeff Olsen

June 3, 2016

Antibiotic-resistant Superbug in U.S.

Deb Balzer

May 27, 2016

Pay Attention to New Labels on Beef

Vivien Williams

May 27, 2016

Mayo Clinic Expert on Zika Virus in the U.S.

Deb Balzer

May 25, 2016

Discovery’s Edge: First Cure With a New Drug

Dana Sparks

May 24, 2016

Mayo Clinic Q and A: HPV Vaccination Series Can Be Started at Age 9

Liza Torborg

May 17, 2016

Explore more topics

Sign up

For Journalists Only Sign up for a Journalist Pass

Mayo Clinic Connect

An online patient support community

Health Topics